APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sphingosine-1-Receptor Modulators Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sphingosine-1-Receptor Modulators Drugs Market Outlook and Growth Opportunities 2026

2 January 2026194 pages

Choose your research edition.

Industry ResearchSphingosine-1-Receptor Modulators Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Sphingosine-1-Receptor Modulators Drugs Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Sphingosine-1-Receptor Modulators Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sphingosine-1-Receptor Modulators Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Sphingosine-1-Receptor Modulators Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Sphingosine-1-Receptor Modulators Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sphingosine-1-Receptor Modulators Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sphingosine-1-Receptor Modulators Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sphingosine-1-Receptor Modulators Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sphingosine-1-Receptor Modulators Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sphingosine-1-Receptor Modulators Drugs market include Sun Pharma, Johnson & Johnson, Novartis, Idorsia, HEC Pharm Co. Limited, Bristol-Myers Squibb, Biocon and Arena Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sphingosine-1-Receptor Modulators Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sphingosine-1-Receptor Modulators Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sphingosine-1-Receptor Modulators Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sphingosine-1-Receptor Modulators Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Sphingosine-1-Receptor Modulators Drugs Segment by Company

Sun Pharma

Johnson & Johnson

Novartis

Idorsia

HEC Pharm Co. Limited

Bristol-Myers Squibb

Biocon

Arena Pharmaceuticals

Sphingosine-1-Receptor Modulators Drugs Segment by Type

Siponimod

Fingolimod

Ozanimod

Other

Sphingosine-1-Receptor Modulators Drugs Segment by Application

Hospital

Clinic

Other

Sphingosine-1-Receptor Modulators Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Sphingosine-1-Receptor Modulators Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sphingosine-1-Receptor Modulators Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sphingosine-1-Receptor Modulators Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Sphingosine-1-Receptor Modulators Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sphingosine-1-Receptor Modulators Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sphingosine-1-Receptor Modulators Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sphingosine-1-Receptor Modulators Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sphingosine-1-Receptor Modulators Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sphingosine-1-Receptor Modulators Drugs industry.

Chapter 3: Detailed analysis of Sphingosine-1-Receptor Modulators Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sphingosine-1-Receptor Modulators Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sphingosine-1-Receptor Modulators Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sphingosine-1-Receptor Modulators Drugs Industry Trends Table 2. Sphingosine-1-Receptor Modulators Drugs Industry Drivers Table 3. Sphingosine-1-Receptor Modulators Drugs Industry Opportunities and Challenges Table 4. Sphingosine-1-Receptor Modulators Drugs Industry Restraints Table 5. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Company (2021-2026) Table 7. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Sphingosine-1-Receptor Modulators Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Sphingosine-1-Receptor Modulators Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sphingosine-1-Receptor Modulators Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Sphingosine-1-Receptor Modulators Drugs Company, Product Type & Application Table 13. Global Sphingosine-1-Receptor Modulators Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sphingosine-1-Receptor Modulators Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Siponimod Table 18. Significant Companies of Fingolimod Table 19. Significant Companies of Ozanimod Table 20. Significant Companies of Other Table 21. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume Share by Type (2021-2026) Table 25. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume Share by Type (2027-2032) Table 26. Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type (2021-2026) Table 30. Global Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Significant Companies of Other Table 34. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume Share by Application (2021-2026) Table 38. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume Share by Application (2027-2032) Table 39. Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application (2021-2026) Table 43. Global Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application (2027-2032) Table 44. Global Sphingosine-1-Receptor Modulators Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Sphingosine-1-Receptor Modulators Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region (2021-2026) Table 47. Global Sphingosine-1-Receptor Modulators Drugs Sales by Region (2027-2032) & (K Units) Table 48. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region (2027-2032) Table 49. Global Sphingosine-1-Receptor Modulators Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Region (2021-2026) Table 52. Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Region (2027-2032) Table 54. Global Sphingosine-1-Receptor Modulators Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Sphingosine-1-Receptor Modulators Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Sphingosine-1-Receptor Modulators Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Sphingosine-1-Receptor Modulators Drugs Sales by Country (2021-2026) & (K Units) Table 59. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2021-2026) Table 60. Global Sphingosine-1-Receptor Modulators Drugs Sales by Country (2027-2032) & (K Units) Table 61. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2027-2032) Table 62. Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Sphingosine-1-Receptor Modulators Drugs Sales Value Market Share by Country (2021-2026) Table 64. Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Sphingosine-1-Receptor Modulators Drugs Sales Value Market Share by Country (2027-2032) Table 66. Sun Pharma Company Information Table 67. Sun Pharma Business Overview Table 68. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 70. Sun Pharma Recent Development Table 71. Johnson & Johnson Company Information Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 75. Johnson & Johnson Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Novartis Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 80. Novartis Recent Development Table 81. Idorsia Company Information Table 82. Idorsia Business Overview Table 83. Idorsia Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Idorsia Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 85. Idorsia Recent Development Table 86. HEC Pharm Co. Limited Company Information Table 87. HEC Pharm Co. Limited Business Overview Table 88. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 90. HEC Pharm Co. Limited Recent Development Table 91. Bristol-Myers Squibb Company Information Table 92. Bristol-Myers Squibb Business Overview Table 93. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 95. Bristol-Myers Squibb Recent Development Table 96. Biocon Company Information Table 97. Biocon Business Overview Table 98. Biocon Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Biocon Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 100. Biocon Recent Development Table 101. Arena Pharmaceuticals Company Information Table 102. Arena Pharmaceuticals Business Overview Table 103. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 105. Arena Pharmaceuticals Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Sphingosine-1-Receptor Modulators Drugs Distributors List Table 109. Sphingosine-1-Receptor Modulators Drugs Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Sphingosine-1-Receptor Modulators Drugs Product Image Figure 2. Global Sphingosine-1-Receptor Modulators Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sphingosine-1-Receptor Modulators Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sphingosine-1-Receptor Modulators Drugs Sales (2021-2032) & (K Units) Figure 5. Global Sphingosine-1-Receptor Modulators Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Sphingosine-1-Receptor Modulators Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Siponimod Image Figure 10. Fingolimod Image Figure 11. Ozanimod Image Figure 12. Other Image Figure 13. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume Share by Type (2021-2032) Figure 16. Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Sphingosine-1-Receptor Modulators Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Other Image Figure 22. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Sphingosine-1-Receptor Modulators Drugs Sales Volume Share by Application (2021-2032) Figure 25. Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Sphingosine-1-Receptor Modulators Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application (2021-2032) Figure 28. Global Sphingosine-1-Receptor Modulators Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Sphingosine-1-Receptor Modulators Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Sphingosine-1-Receptor Modulators Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. North America Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Sphingosine-1-Receptor Modulators Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Sphingosine-1-Receptor Modulators Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Sphingosine-1-Receptor Modulators Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. South America Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Sphingosine-1-Receptor Modulators Drugs Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Sphingosine-1-Receptor Modulators Drugs Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Siponimod
  • Fingolimod
  • Ozanimod
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Sun Pharma
  • Johnson & Johnson
  • Novartis
  • Idorsia
  • HEC Pharm Co. Limited
  • Bristol-Myers Squibb
  • Biocon
  • Arena Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sphingosine-1-Receptor Modulators Drugs Market Dynamics
  1. 2.1 Sphingosine-1-Receptor Modulators Drugs Industry Trends
  2. 2.2 Sphingosine-1-Receptor Modulators Drugs Industry Drivers
  3. 2.3 Sphingosine-1-Receptor Modulators Drugs Industry Opportunities and Challenges
  4. 2.4 Sphingosine-1-Receptor Modulators Drugs Industry Restraints
3 Sphingosine-1-Receptor Modulators Drugs Market by Company
  1. 3.1 Global Sphingosine-1-Receptor Modulators Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Sphingosine-1-Receptor Modulators Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Sphingosine-1-Receptor Modulators Drugs Company Ranking (2024-2026)
  6. 3.6 Global Sphingosine-1-Receptor Modulators Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Sphingosine-1-Receptor Modulators Drugs Company Product Type and Application
  8. 3.8 Global Sphingosine-1-Receptor Modulators Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sphingosine-1-Receptor Modulators Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sphingosine-1-Receptor Modulators Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sphingosine-1-Receptor Modulators Drugs Market by Type
  1. 4.1 Sphingosine-1-Receptor Modulators Drugs Type Introduction
  2. 4.1.1 Siponimod
  3. 4.1.2 Fingolimod
  4. 4.1.3 Ozanimod
  5. 4.1.4 Other
  6. 4.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Type
  7. 4.2.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Type
  11. 4.3.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Type (2021-2032)
  13. 4.3.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type (2021-2032)
5 Sphingosine-1-Receptor Modulators Drugs Market by Application
  1. 5.1 Sphingosine-1-Receptor Modulators Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Application
  6. 5.2.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Application
  10. 5.3.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application (2021-2032)
6 Sphingosine-1-Receptor Modulators Drugs Regional Sales and Value Analysis
  1. 6.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region (2027-2032)
  5. 6.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Sphingosine-1-Receptor Modulators Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sphingosine-1-Receptor Modulators Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sphingosine-1-Receptor Modulators Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sphingosine-1-Receptor Modulators Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sphingosine-1-Receptor Modulators Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Country, 2025 VS 2032
7 Sphingosine-1-Receptor Modulators Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sphingosine-1-Receptor Modulators Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Country (2027-2032)
  6. 7.4 Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sphingosine-1-Receptor Modulators Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sphingosine-1-Receptor Modulators Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharma
  2. 8.1.1 Sun Pharma Company Information
  3. 8.1.2 Sun Pharma Business Overview
  4. 8.1.3 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  6. 8.1.5 Sun Pharma Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Sphingosine-1-Receptor Modulators Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Idorsia
  20. 8.4.1 Idorsia Company Information
  21. 8.4.2 Idorsia Business Overview
  22. 8.4.3 Idorsia Sphingosine-1-Receptor Modulators Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Idorsia Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  24. 8.4.5 Idorsia Recent Developments
  25. 8.5 HEC Pharm Co. Limited
  26. 8.5.1 HEC Pharm Co. Limited Company Information
  27. 8.5.2 HEC Pharm Co. Limited Business Overview
  28. 8.5.3 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  30. 8.5.5 HEC Pharm Co. Limited Recent Developments
  31. 8.6 Bristol-Myers Squibb
  32. 8.6.1 Bristol-Myers Squibb Company Information
  33. 8.6.2 Bristol-Myers Squibb Business Overview
  34. 8.6.3 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  36. 8.6.5 Bristol-Myers Squibb Recent Developments
  37. 8.7 Biocon
  38. 8.7.1 Biocon Company Information
  39. 8.7.2 Biocon Business Overview
  40. 8.7.3 Biocon Sphingosine-1-Receptor Modulators Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Biocon Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  42. 8.7.5 Biocon Recent Developments
  43. 8.8 Arena Pharmaceuticals
  44. 8.8.1 Arena Pharmaceuticals Company Information
  45. 8.8.2 Arena Pharmaceuticals Business Overview
  46. 8.8.3 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  48. 8.8.5 Arena Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sphingosine-1-Receptor Modulators Drugs Value Chain Analysis
  2. 9.1.1 Sphingosine-1-Receptor Modulators Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sphingosine-1-Receptor Modulators Drugs Sales Mode & Process
  6. 9.2 Sphingosine-1-Receptor Modulators Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sphingosine-1-Receptor Modulators Drugs Distributors
  9. 9.2.3 Sphingosine-1-Receptor Modulators Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst